Page last updated: 2024-10-18

dihydroxyphenylalanine and Dermatitis Medicamentosa

dihydroxyphenylalanine has been researched along with Dermatitis Medicamentosa in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schnur, JA1
Chase, TN1
Brody, JA1

Other Studies

1 other study available for dihydroxyphenylalanine and Dermatitis Medicamentosa

ArticleYear
Parkinsonism-dementia of Guam: treatment with L-dopa.
    Neurology, 1971, Volume: 21, Issue:12

    Topics: Adult; Dementia; Dihydroxyphenylalanine; Drug Eruptions; Female; Humans; Hydroxyindoleacetic Acid; H

1971